Ultragenyx Pharma (RARE) Misses Q4 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 16.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.30 | 52 Week High | $117.12 | |||
| Open | $16.30 | 52 Week Low | $46.52 | |||
| Day High | $16.30 | P/E | N/A | |||
| Day Low | $16.30 | EPS | $-1.97 | |||
| Volume | 4,298 | |||||
